EAM Investors’s NEVRO CORP. NVRO Stock Holding History

EAM Investors’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-16,288	Closed	-$1.63M	–	336
2020 Q1	$1.63M	Sell	16,288 -767	-4%	-$92.3K	0.51%	89
2019 Q4	$2M	Buy	+17,055	New	+$1.69M	0.44%	75
2016 Q4	–	Sell	-33,683	Closed	-$3.52M	–	373
2016 Q3	$3.52M	Sell	33,683 -875	-3%	-$79K	0.47%	52
2016 Q2	$2.55M	Buy	34,558 +1,387	+4%	+$94.1K	0.38%	132
2016 Q1	$1.87M	Sell	33,171 -26,481	-44%	-$1.56M	0.29%	160
2015 Q4	$4.03M	Sell	59,652 -1,043	-2%	-$55.9K	0.53%	43
2015 Q3	$2.82M	Sell	60,695 -36,134	-37%	-$1.75M	0.45%	72
2015 Q2	$5.21M	Sell	96,829 -4,910	-5%	-$250K	0.61%	20
2015 Q1	$4.88M	Buy	101,739 +72,575	+249%	+$3.15M	0.56%	21
2014 Q4	$1.13M	Buy	+29,164	New	+$918K	0.16%	270

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

EAM Investors's NVRO Position: Q2 2020 in Review

EAM Investors sold out of NEVRO CORP. (NVRO) in Q2 2020, closing a stake of 16,288 shares — an estimated $1.63M sold.

EAM Investors first reported a position in NVRO in Q4 2014 and held it in 10 quarters. The position peaked at $5.21M in Q2 2015. 202 funds tracked by Wall St. Rank hold NVRO as of Q2 2020.

EAM Investors reported no remaining NEVRO CORP. position as of Q2 2020 after selling out during the quarter.
EAM Investors sold 16,288 NEVRO CORP. shares in Q2 2020, an estimated $1.63M.
EAM Investors first reported a position in NEVRO CORP. in Q4 2014 and held it in 10 quarters.
EAM Investors's NEVRO CORP. position peaked at $5.21M in Q2 2015.
202 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2020.

Based on EAM Investors's 13F filing for Q2 2020, filed 13 Aug 2020.